Tales From the 2022 Biotech VC Fundraising Trail

December 22, 2022

After the bonanza of 2021, life-sciences entrepreneurs reset their expectations as financing contracted

Biotechnology entrepreneurs recalibrated in 2022 as their financing options narrowed, a reversal from years in which life-sciences startups were flush with capital.

With just two weeks left in the year, U.S. biotechs had raked in $29.7 billion for 2022, compared with the record—$38.7 billion—deployed in all of 2021, according to market tracker PitchBook Data Inc.